Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$0.6 - $1.65 $42 - $115
70 New
70 $0
Q1 2023

May 15, 2023

SELL
$4.89 - $12.27 $10,919 - $27,398
-2,233 Reduced 64.91%
1,207 $5,000
Q4 2022

Feb 10, 2023

SELL
$8.88 - $12.77 $133 - $191
-15 Reduced 0.43%
3,440 $36,000
Q3 2022

Nov 10, 2022

BUY
$8.24 - $12.56 $6,855 - $10,449
832 Added 31.72%
3,455 $32,000
Q2 2022

Aug 12, 2022

BUY
$7.45 - $13.84 $7,561 - $14,047
1,015 Added 63.12%
2,623 $23,000
Q1 2022

May 12, 2022

SELL
$9.94 - $12.65 $2,107 - $2,681
-212 Reduced 11.65%
1,608 $19,000
Q4 2021

Feb 11, 2022

SELL
$11.99 - $18.14 $17,769 - $26,883
-1,482 Reduced 44.88%
1,820 $22,000
Q3 2021

Nov 05, 2021

BUY
$11.55 - $16.06 $18,514 - $25,744
1,603 Added 94.35%
3,302 $51,000
Q2 2021

Aug 06, 2021

BUY
$12.38 - $29.19 $19,869 - $46,849
1,605 Added 1707.45%
1,699 $24,000
Q4 2020

Feb 12, 2021

SELL
$12.72 - $16.16 $2,544 - $3,232
-200 Reduced 68.03%
94 $1,000
Q1 2020

May 08, 2020

SELL
$9.12 - $17.78 $8,490 - $16,553
-931 Reduced 76.0%
294 $3,000
Q3 2019

Nov 08, 2019

SELL
$18.28 - $26.91 $15,081 - $22,200
-825 Reduced 40.24%
1,225 $22,000
Q2 2019

Aug 09, 2019

BUY
$17.68 - $21.57 $4,420 - $5,392
250 Added 13.89%
2,050 $0
Q3 2018

Nov 09, 2018

SELL
$17.57 - $23.95 $14,056 - $19,160
-800 Reduced 30.77%
1,800 $0
Q2 2018

Aug 10, 2018

SELL
$11.6 - $19.27 $23,200 - $38,540
-2,000 Reduced 43.48%
2,600 $0
Q3 2017

Nov 13, 2017

BUY
$12.6 - $16.34 $57,960 - $75,164
4,600
4,600 $0

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $14.5M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.